Your browser doesn't support javascript.
loading
Degradative Effect of Nattokinase on Spike Protein of SARS-CoV-2.
Tanikawa, Takashi; Kiba, Yuka; Yu, James; Hsu, Kate; Chen, Shinder; Ishii, Ayako; Yokogawa, Takami; Suzuki, Ryuichiro; Inoue, Yutaka; Kitamura, Masashi.
Afiliación
  • Tanikawa T; Laboratory of Nutri-Pharmacotherapeutics Management, School of Pharmacy, Faculty of Pharmacy and Pharmaceutical Sciences, Josai University, Saitama 350-0295, Japan.
  • Kiba Y; Laboratory of Pharmacognocy, School of Pharmacy, Faculty of Pharmacy and Pharmaceutical Sciences, Josai University, Saitama 350-0295, Japan.
  • Yu J; Contek Life Science Co., Ltd., Taipei City 100007, Taiwan.
  • Hsu K; Contek Life Science Co., Ltd., Taipei City 100007, Taiwan.
  • Chen S; Contek Life Science Co., Ltd., Taipei City 100007, Taiwan.
  • Ishii A; CellMark Japan, Tokyo 102-0071, Japan.
  • Yokogawa T; Laboratory of Pharmacognocy, School of Pharmacy, Faculty of Pharmacy and Pharmaceutical Sciences, Josai University, Saitama 350-0295, Japan.
  • Suzuki R; Laboratory of Natural Products & Phytochemistry, Department of Pharmaceutical Sciences, Faculty of Pharmacy and Pharmaceutical Sciences, Josai University, Saitama 350-0295, Japan.
  • Inoue Y; Laboratory of Nutri-Pharmacotherapeutics Management, School of Pharmacy, Faculty of Pharmacy and Pharmaceutical Sciences, Josai University, Saitama 350-0295, Japan.
  • Kitamura M; Laboratory of Pharmacognocy, School of Pharmacy, Faculty of Pharmacy and Pharmaceutical Sciences, Josai University, Saitama 350-0295, Japan.
Molecules ; 27(17)2022 Aug 24.
Article en En | MEDLINE | ID: mdl-36080170

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / Tratamiento Farmacológico de COVID-19 Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / Tratamiento Farmacológico de COVID-19 Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article